Qingdao Baheal Medical (301015.SZ) Earnings Analysis

Qingdao Baheal Medical (301015.SZ) has no confirmed upcoming earnings date. Trailing P/E 24.04.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 301015.SZ next report earnings?

No confirmed upcoming earnings date is currently scheduled for 301015.SZ. This page updates as the calendar is published.

301015.SZ earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-290.24 CNYn/an/an/a
2025-10-300.59 CNYn/an/an/a
2025-08-290.147 CNYn/an/an/a
2025-04-240.09443 CNYn/an/an/a
2025-03-310.16 CNYn/an/an/a
2024-10-250.5 CNYn/an/an/a

301015.SZ valuation and analyst view

Trailing P/E24.04
Trailing EPS0.99456 CNY
Price / book4.73
Dividend yield2.41%
Market cap12.36B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is Qingdao Baheal Medical (301015.SZ)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for 301015.SZ. This page updates as the calendar is published.

Did 301015.SZ beat earnings last quarter?

Consensus estimate data was not available for 301015.SZ's 2026-04-29 report.

What is 301015.SZ's current P/E ratio and EPS?

301015.SZ trades at a trailing P/E of 24.04 on trailing EPS of 0.994555187246424 CNY.

What do analysts rate 301015.SZ?

301015.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.